Biotech News

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine (HYPR)HyperfineConference / presentation

Prospective randomized ED study shows rapid bedside imaging, detection of critical neurological findings, and potential workflow efficiency benefits with portable MRI GUILFORD, Conn. --(BUSINESS WIRE)--May 22, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that

Open original release

Related news

Hyperfine

Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.

Recent company news

Stock data

Close
0.96 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States